PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Micropathology Limited
MI

Micropathology Limited

Coventry
SME

Micropathology Limited is a UK-based rapid diagnosis pathology laboratory that offers clinically supported diagnostics for infectious and genetic diseases. They also engage in biomedical research and provide genetic profiling services.

micropathology.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£196k
Live
6
Buyers
8
12m
£186k
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts6 / 8
  • Top buyers8
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Micropathology LimitedUpdated 20 Jul 2026

At a glance · for buyers and watchdogs

Micropathology Limited has won £196k across 8 public-sector buyers, with 6 live contracts. No active Companies House risk flags.

Why: top buyer NHS Blood & Transplant (NHSBT) at 95% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
6 of 8Live contracts
95%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 5
SequencingSanger and Next-Generation sequencing. ↗Pathogen DetectionRapid detection of pathogens and host responses. ↗Antibody/Antigen DetectionRapid detection of specific antibodies in human and veterinary samples. ↗GeneticsGenetic Profiling for human identification. ↗Biomedical ResearchUndertaking grant-aided research with universities and other research companies. ↗

Extracted automatically from micropathology.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 6 live · 2 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Supply of Bacterial Gene Detection and Sequencing
NHS Blood & Transplant (NHSBT)—01 Jun 2026£186k4 yrspending
SO to cover the cost of referred tests (July 2022 to Jun 2023)
CALDERDALE AND HUDDERSFIELD SOLUTIONS LTD7190000001 Jul 2022£10k12 moClosed
Supply of Bacterial Gene Detection and Sequencing
NHS Blood and Transplant————Live
Microbiology Referrals - Micropathology Ltd
Gateshead Health NHS Foundation Trust————Live
DON - Pathology referred samples 26/27
Sheffield Teaching Hospitals NHS Foundation Trust————Live
The Provision of Molecular Referral Laboratory Specialist Services
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST85111800———Live
CALL OFF ORDER FOR THE REFERALL OF MICROBIOLOGY TESTS
Integrated Laboratory Solutions LLP————Live
Provision of Virology/Bacterial Testing Services by Micropathology Ltd
Gloucestershire Hospitals NHS Foundation Trust85111800———Live
Total live value — · mean award £25k

Top buyers · 8 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS Blood & Transplant (NHSBT)
1 contract
95%
since 2026
2
CALDERDALE AND HUDDERSFIELD SOLUTIONS LTD
1 contract
5%
since 2022
3
NHS Blood and Transplant
1 contract
0%
4
Gateshead Health NHS Foundation Trust
1 contract
0%
5
Sheffield Teaching Hospitals NHS Foundation Trust
1 contract
0%
6
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST
1 contract
0%
7
Integrated Laboratory Solutions LLP
1 contract
0%
8
Gloucestershire Hospitals NHS Foundation Trust
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
South West3 contracts
95%
Yorkshire3 contracts
5%
North East1 contract
0%
East Midlands1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Micropathology Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
RD
Roche Diagnostics Ltd
No£207.9m14
AT
Abbott Toxicology Ltd
Yes£38.7m2
AS
Asbestech Ltd
Yes£27.2m4
AC
ASPECT CONTRACTS LIMITED
Yes£27.2m4
MC
McHale Cotracts and Plant Environmental LLP
Yes£27.2m3
MI
Micropathology Limited
Yes£186k—
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 28 Feb 2025
Confirmation statement
Up to date
Next due 14 Feb 2027
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
03022426
Status
Active
Type
Private limited
Incorporated
15 Feb 1995
Reg. office
The Venture Centre Sir William Lyons Road, University Of Warwick Science Park, Coventry, CV4 7EZ
SIC codes
72190 · 86900
Last accounts
28 Feb 2025
Next accounts due
30 Nov 2026

Directors & PSC

  • BUTLER, Lucilla — director
    Appointed 15 Apr 2024
  • FINK, Colin Graham, Dr — secretary
    Appointed 20 Nov 2010
  • FINK, Colin Graham, Dr — director
    Appointed 03 Oct 2001
  • Dr Colin Graham Fink — person with significant control
    ownership of shares 50 to 75 percent · voting rights 75 to 100 percent
  • Miss Lucy Butler — person with significant control
    ownership of shares 25 to 50 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
MICROPATHOLOGY LIMITED
03022426 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.